INS and type 1 diabetes mellitus: Intensive insulin therapy aiming at good glycemic control significantly reduces microvascular and macrovascular complications.1,2 However, hypoglycemia remains the major barrier to achieve glycemic targets,3 and more than 70% of people with type 1 diabetes do not achieve glycemic targets despite advances in insulin analogues, educational programs, insulin pumps, and glucose sensors.4